medigraphic.com
Colegio de Medicina Interna de México.

2021, Number 2

<< Back Next >>

Med Int Mex 2021; 37 (2)

Pheochromocytoma

Polanía-Andrade ÁN, Monroy-Tovar LF, Alarcón-Vargas ÁM, Barrios-Torres JC, Vargas HI

Language: Spanish
References: 32
Page: 288-295
PDF size: 339.21 Kb.


ABSTRACT

Background: Pheochromocytoma is a tumor derived from the chromaffin tissues, most of the tumors are located at the adrenal glands, although there are extraadrenal locations. Incidence worldwide is two to eight cases per million of inhabitants each year.
Clinical case: A 33-year-old male patient with history of type 1 neurofibromatosis and long-term arterial hypertension with difficult control who consulted to the emergency service because of exacerbation of cardiac symptoms. Patient was diagnosed with pheochromocytoma and was treated with adrenalectomy.
Conclusions: Pheochromocytoma must be suspected in young patients with difficult control hypertension and risk factors, especially patients with familial antecedents of pheochromocytoma or genetic alterations such as neurofibromatosis.


REFERENCES

  1. Ortellado N, Carísimo M, Huber G. Feocromocitoma: manejo anestésico transoperatorio. A propósito de un caso y revisión de la literatura. An Fac Cienc Méd (Asunción) 2008; 41 (1-2): 64-74.

  2. Subramaniam R. Pheochromocytoma: Current concepts in diagnosis and management. Trends Anaesth Crit Care 2011; 1 (2): 104-10. http://dx.doi.org/10.1016/j. tacc.2011.01.009.

  3. Nguyen-Martín MA, Hammer GD. Pheochromocytoma: an update on risk groups, diagnosis and management. Hosp Physician 2006: 17-24.

  4. Angeli A, Osella G, Ali A, Terzolo M. Adrenal incidentaloma: an overview of clinical and epidemiological data from the National Italian Study Group. Horm Res 1997; 47 (4-6): 279-283. doi. 10.1159/000185477.

  5. Kebebew E, Siperstein AE, Clark OH, Duh QY. Results of laparoscopic adrenalectomy for suspected and unsuspected malignant adrenalneoplasms. Arch Surg 2002; 137 (8): 948-953. doi. 10.1001/archsurg.137.8.948.

  6. Novoa EC, Segura JC. Feocromocitoma y manejo anestésico perioperatorio: reporte de caso. Univ Médica 2014; 55 (2): 220-8.

  7. Matsuda T, Murota T, Oguchi N, Kawa G, et al. Laparoscopic adrenalectomy for pheochromocytoma: a literature review. Biomed Pharmacother 2002; 56 Suppl 1: 132s-138s. doi. 10.1016/S0753-3322(02)00231-7.

  8. Karasek D, Shah U, Frysak Z, Stratakis C, et al. An update on the genetics of pheochromocytoma. J Hum Hypertens 2013; 27: 141-147. doi. 10.1038/jhh.2012.20.

  9. Berends A, Buitenwerfa E, De Krijgerb R, Veegerc N, et al. Incidence of pheochromocytoma and sympathetic paraganglioma in the Netherlands: A nationwide study and systematic review. Eur J Intern Med 2018; S0953- 6205(18)30015-3 doi. 10.1016/j.ejim.2018.01.015.

  10. Guzmán G, Casas LA, Navarro EP, Arango L. Experiencia en el manejo de feocromocitoma en los últimos 10 años: serie de casos. Revista Colombiana de Endocrinología, Diabetes & Metabolismo 2017; 3 (3): 33-36.

  11. Manger WM, Gifford RW. Pheochromocytoma. J Clin Hypertens (Greenwich) 2002; 4: 62. doi. 10.1111/j.1524- 6175.2002.01452.x.

  12. Stein PP, Black HR. A simplified diagnostic approach to pheochromocytoma. A review of the literature and report of one institution’s experience. Medicine (Baltimore) 1991; 70: 46. doi. 10.1097/00005792-199101000-00004.

  13. Lenders JW, Eisenhofer G, Mannelli M, Pacak K. Pheochromocytoma. Lancet 2005; 366 (9486): 665-675. DOI. https:// doi.org/10.1016/S0140-6736(05)67139-5.

  14. Mannelli M, Bemporad D. Diagnosis and management of pheochromocytoma during pregnancy. J Endocrinol Invest 2002; 25 (6): 567-71. doi. http://doi.org/10.1007/ BF03345503.

  15. Neumann HP, Berger DP, Sigmund G, Blum U, et al. Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease. N Engl J Med 1993; 329: 1531. doi. 10.1056/NEJM199412013312229.

  16. Walther MM, Herring J, Enquist E, Keiser HR, et al. von Recklinghausen’s disease and pheochromocytomas. J Urol 1999; 162: 1582. doi. https://doi.org/10.1016/S0022- 5347(05)68171-2.

  17. Virseda-Rodríguez JA, Martínez-Ruiz J, Carrión-López P, Martínez-Sanchiz C, et al. Feocromocitoma: más de una década de experiencia. Revisión de la literatura. Actas Urol Esp 2010; 34 (10): 888-892.

  18. Berkel V, Lenders JW, Timmers HJ. Diagnosis of endocrine disease: Biochemical diagnosis of pheochromocytoma and paraganglioma. Eur J Endocrinol 2014; 170 (3): 109-19. doi. 10.1530/EJE-13-0882.

  19. Lenders J, Pacak K, Walther MM, Linehan W, et al. Biochemical diagnosis of pheochromocytoma which test is best? JAMA 2002; 287 (11): 1427-34 doi.10.1001/ jama.287.11.1427.

  20. Lee JA, Zarnegar R, Shen WT, Kebebew E, et al. Adrenal incidentaloma, borderline elevations of urine or plasma metanephrine levels, and the “subclinical” pheochromocytoma Arch Surg 2007; 142 (9): 870-3. doi. 10.1001/ archsurg.142.9.870.

  21. Bravo EL. Evolving concepts in the pathophysiology, diagnosis and treatment of pheochromocytoma. Endocr Rev 1994; 15 (3): 356-368. http://dx.doi.org/10.1210/edrv-15-3-356.

  22. Bravo EL, Tagle R. Pheochromocytomas: State of the art and future prospects. Endocr Rev 2003; 24 (4): 539-553. http://dx.doi.org/10.1210/er.2002-0013.

  23. Bernal C, Alcázar JM. Feocromocitoma: presentación clínica. Diagnóstico y tratamiento. Hipertens y Riesgo Vasc 2006; 23 (6): 173-83. doi. 10.1016/S1889-1837(06)71631- 2.

  24. Oleaga A, Goñi F. Feocromocitoma: actualización diagnóstica y terapéutica. Endocrinol Nutr 2008; 55 (5): 202-16. doi. 10.1016/S1575-0922(08)70669-7.

  25. Khanna S, Priya R, Bhartiya SK, Basu S, et al. Adrenal tumors: An experience of 10 years in a single surgical unit. Indian J Cancer 2015; 52 (3): 475-8. DOI. 10.4103/0019- 509X.176749.

  26. Bednarczuk T, Bolanowski M, Sworczak K, Górnicka B, et al. Adrenal incidentaloma in adults — management recommendations by the Polish Society of Endocrinology. Endokrynol Pol 2016; 67 (2): 234-58. doi. 10.5603/ EP.a2016.0039.

  27. Sánchez R. Feocromocitoma: Diagnóstico y tratamiento. Rev Mex Cardiol 2010; 21 (3): 124-137.

  28. Welbourn RB. Early surgical history of pheochromocytoma. Br J Surg 1987; 74: 594-596. doi. 10.1002/bjs.1800740717.

  29. Favia G, Lumachi F, Polistina F, D’Amico DF. Pheochromocytoma, a rare cause of hypertension: long-term follow-up of 55 surgically treated patients. World J Surg 1998; 22: 689-693. [discussion 694]. doi. http://doi.org/10.1007/ s002689900454.

  30. Hodin R, Lubitz C, Phitayakorn R, Stephen A. Diagnosis and management of pheochromocytoma. Curr Probl Surg 2014; 51: 151-187. doi. https://doi.org/10.1067/j. cpsurg.2013.12.001.

  31. Tauzin-Fin P, Sesay M, Gosse P, Ballanger P. Effects of perioperative alpha 1 block on haemodynamic control during laparoscopic surgery for pheochromocytoma. Br J Anaesth 2004; 92: 512-517. doi. https://doi.org/10.1093/ bja/aeh083.

  32. Kinney MA, Narr BJ, Warner MA. Perioperative management of pheochromocytoma. J Cardiothorac Vasc Anesth 2002; 16: 359-369. doi. https://doi.org/10.1053/ jcan.2002.124150.




2020     |     www.medigraphic.com